GLP-1 Probiotics
Cross-source consensus on GLP-1 Probiotics from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Benefits
Comparisons
Evidence quality
Highlighted claims
- A five-strain probiotic containing Akkermansia, Clostridium butyricum, Bifidobacterium infantis, and two additional strains was tested in type 2 diabetes patients. — Gut Microbiome, Estrobolome, and Women's Metabolic Health Through Menopause
- The full five-strain formulation decreased postprandial glucose spikes by 33% in the trial table. — Gut Microbiome, Estrobolome, and Women's Metabolic Health Through Menopause
- The full five-strain formulation decreased A1C by 6% in the trial table. — Gut Microbiome, Estrobolome, and Women's Metabolic Health Through Menopause
- The article describes a 6% A1C reduction as clinically significant and comparable to reductions from common diabetes medications. — Gut Microbiome, Estrobolome, and Women's Metabolic Health Through Menopause
- A food cravings study reported statistically significant reductions across tested categories after six weeks on the GLP-1 probiotic formulation. — Gut Microbiome, Estrobolome, and Women's Metabolic Health Through Menopause
- Healthcare providers reported using GLP-1 probiotics as an off-ramp or adjunct to GLP-1 medications. — Gut Microbiome, Estrobolome, and Women's Metabolic Health Through Menopause